EASD 2023 - All about incretins and incretin-based therapies for diabetes treatment @EASDiabetes
EASD 2023 - All about incretins and incretin-based therapies for diabetes treatment  @EASDiabetes
Uploaded November 2023 | Updated September 2026, 3 days ago
Jens Holst, Fiona Gribble, Erin Mulvihill and Jonathan Campbell took the EASD TV audience on a journey to the incredible incretins. Incretins are the hormones from the gut that enhance insulin secretion when you eat. They decribed their mode of action, how gut hormones are released and what effects incretin-based therapies have on #diabetes and #obesity.
#EASD2023 #hormones #weightloss
EASD 2023 - All about incretins and incretin-based therapies for diabetes treatment#EASD2022 Interview with the 2022 EASD Morgagni Prize awardee Olga Ramlich and Chair Miriam Cnop60th EASD Annual Meeting - Six decades of progress in diabetes research, care and collaborationEASD 2025: How Might Anti-Obesity Medication Look Like in the Future?EASD 2025: AI in Diabetes - Can AI Really Transform Diabetes Care?Developing Clinical Practice Guidelines – Methodological Standards and Common PitfallsEASD 2024 - Can we Screen for Type 2 Diabetes Using Voice Recognition?7th EASD Early Career Academy Webinar: Grant writing tips for successEASD 2024 Interview with Dr. Lori Sussel - 18th Albert Renold Prize WinnerEASD 2024 - Saving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW TrialEASD 2023 - Chantal Mathieu, Abd Tharani and Amalia Gastaldelli about career developmentEASD 2025: Portrait Teresa Mezza - Recipient of the 60th EASD Minkowski Prize 2025
European Association for the Study of Diabetes |

EASD 2023 - All about incretins and incretin-based therapies for diabetes treatment

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER